Prevalence, risk factors and potential implications of nail biting in adults with congenital heart disease.

Adult congenital heart disease Endocarditis risk Nail biting Patient education

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 03 09 2024
revised: 27 09 2024
accepted: 13 10 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 16 10 2024
Statut: aheadofprint

Résumé

Nail biting is a habit with potential health implications. Patients with congenital heart disease (CHD) are at increased risk of infections, with endocarditis being a particularly significant concern. Our aim was to establish the magnitude of this modifiable potential risk factor, namely nail biting, in a contemporary cohort of adult with CHD (ACHD). Our prospective study included consecutive, unselected ACHD patients, categorised on nail-biting habits, analysing background demographics, health records, and behavioural factors. Of the 310 patients enrolled, 101 (33 %) were found to be current nail biters. Univariate logistic analysis revealed that younger age (OR: 1.30/10 years, p = 0.002), male gender (OR: 1.73, p = 0.029), greater CHD complexity (OR: 2.15, p = 0.002) and learning disability (OR: 3.51, p = 0.031) were associated with a significantly higher risk of nail biting. Multivariable analysis confirmed that younger age (OR: 1.29, p = 0.010), greater CHD complexity (OR: 1.89, p = 0.016), obesity (OR: 1.75, p = 0.038) and learning disability (OR: 3,87, p = 0.030) were significant predictors for nail biting. A third of ACHD patients attending a tertiary centre engage in nail biting, which may have detrimental effects. Such behaviour was more prevalent among younger, obese, complex CHD patients and those with learning disability. Lifestyle education and/or modifications warrant further improvement in this growing patient population.

Sections du résumé

BACKGROUND BACKGROUND
Nail biting is a habit with potential health implications. Patients with congenital heart disease (CHD) are at increased risk of infections, with endocarditis being a particularly significant concern. Our aim was to establish the magnitude of this modifiable potential risk factor, namely nail biting, in a contemporary cohort of adult with CHD (ACHD).
METHODS METHODS
Our prospective study included consecutive, unselected ACHD patients, categorised on nail-biting habits, analysing background demographics, health records, and behavioural factors.
RESULTS RESULTS
Of the 310 patients enrolled, 101 (33 %) were found to be current nail biters. Univariate logistic analysis revealed that younger age (OR: 1.30/10 years, p = 0.002), male gender (OR: 1.73, p = 0.029), greater CHD complexity (OR: 2.15, p = 0.002) and learning disability (OR: 3.51, p = 0.031) were associated with a significantly higher risk of nail biting. Multivariable analysis confirmed that younger age (OR: 1.29, p = 0.010), greater CHD complexity (OR: 1.89, p = 0.016), obesity (OR: 1.75, p = 0.038) and learning disability (OR: 3,87, p = 0.030) were significant predictors for nail biting.
CONCLUSION CONCLUSIONS
A third of ACHD patients attending a tertiary centre engage in nail biting, which may have detrimental effects. Such behaviour was more prevalent among younger, obese, complex CHD patients and those with learning disability. Lifestyle education and/or modifications warrant further improvement in this growing patient population.

Identifiants

pubmed: 39414153
pii: S0167-5273(24)01274-9
doi: 10.1016/j.ijcard.2024.132652
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132652

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no relationships that could be construed as a conflict of interest. Two authors (GPD and MAG) are on the Editorial Board of the International Journal of Cardiology.

Auteurs

Masahiko Umei (M)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: m-umei@umin.ac.jp.

Ariuntsatsral Erdenebileg (A)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; Cardiovascular Care, Intermed Hospital, Ulaanbaatar, Mongolia.

Joyce Lim (J)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK.

Ioanna Giannakopoulou (I)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK.

Stefano Svab (S)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; Adult Congenital Heart Centre, St Thomas' Hospital, Guys & St Thomas's NHS Trust, London, UK.

Charo Bruce (C)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK.

Polona Kacar (P)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK.

Giulia Iannaccone (G)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Hajar Habibi (H)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; National Heart & Lung Institute, Imperial College, London, UK.

Gerhard-Paul Diller (GP)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; National Heart & Lung Institute, Imperial College, London, UK; Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Muenster, Germany.

Michael A Gatzoulis (MA)

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guys & St Thomas's NHS Trust, London, UK; National Heart & Lung Institute, Imperial College, London, UK.

Classifications MeSH